View Single Post
  #11   ^
Old Mon, Apr-08-13, 01:49
RawNut's Avatar
RawNut RawNut is offline
Lipivore
Posts: 1,208
 
Plan: Very Low Carb Paleo
Stats: 270/185/180 Male 72 inches
BF:
Progress: 94%
Location: Florida
Default


It doesn't jibe.




A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction

Quote:
"Angina pectoris (17.6 vs 36.0%), New York Heart Association class III and IV heart failure plus left ventricular enlargement (23.4 vs 36.0%) and total arrhythmias (13.7 vs 28.0%) were significantly less in the carnitine group compared to placebo. Total cardiac events including cardiac deaths and nonfatal infarction were 15.6% in the carnitine group vs 26.0% in the placebo group"


Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration

Quote:
"There were 6 deaths in the placebo group and 1 death in the L-carnitine group. Survival analysis with the Kaplan-Meier method showed that patients' survival was statistically significant (P <.04) in favor of the L-carnitine group. L-carnitine appears to possess considerable potential for the long-term treatment of patients with heart failure attributable to dilated cardiomyopathy"


Controlled study on L-carnitine therapeutic efficacy in post-infarction

Quote:
"L-carnitine was randomly administered to 81 patients at an oral dose of g 4/die for 12 months, in addition to the pharmacological treatment generally used. For the whole period of 12 months, these patients showed, in comparison with the controls, an improvement in heart rate (p < 0.005), systolic arterial pressure (p < 0.005) and diastolic arterial pressure (NS); a decrease of anginal attacks (p < 0.005), of rhythm disorders (NS) and of clinical signs of impaired myocardial contractility (NS), and a clear improvement in the lipid pattern (p < 0.005). The above changes were accompanied by a lower mortality in the treated group (1.2%, p < 0.005), while in the control group there was a mortality of 12.5%"



Reply With Quote